Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Journal of the National Cancer Institute|October 4, 1995
Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibodyS Canevari, G Stoter, F Arienti, et al.European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.Journal of Medicinal Chemistry|December 1, 1988
Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stabilityJ J Plattner, P A Marcotte, H D Kleinert, et al.European Journal of Gynaecological Oncology|January 1, 1995
High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experienceJ B Vermorken, A Kobierska, M E van der Burg, et al.Gynecologic Oncology|September 7, 2016
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 studyG Mangili, J Ottolina, G Cormio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.Gynecologic Oncology|May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of CancerH C Wagenaar, N Colombo, I Vergote, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.Pageof 11